688089 logo

Cabio Biotech (Wuhan) Co., Ltd. Stock Price

SHSE:688089 Community·CN¥2.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

688089 Share Price Performance

CN¥0
-25.11 (-100.00%)
CN¥0
-25.11 (-100.00%)
Price CN¥0

688089 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and good value.

2 Risks
1 Reward

Cabio Biotech (Wuhan) Co., Ltd. Key Details

CN¥418.2m

Revenue

CN¥236.7m

Cost of Revenue

CN¥181.5m

Gross Profit

CN¥126.4m

Other Expenses

CN¥55.2m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.33
43.41%
13.19%
12.9%
View Full Analysis

About 688089

Founded
1999
Employees
574
CEO
Dewei Yi
WebsiteView website
www.cabio.cn

Cabio Biotech (Wuhan) Co., Ltd. develops, produces, and markets arachidonic and docosahexaenoic acids, and beta-carotene for domestic and foreign infant formula, and healthy food manufacturers. It offers human and animal nutrition, personal care, and synthetic biology products. The company was founded in 1999 and is based in Wuhan, the People’s Republic of China.

Recent 688089 News & Updates

Recent updates

No updates